CRESCENT BIOPHARMA INC (CBIO) Stock Cash Flow
NASDAQ:CBIO - Nasdaq - US38000Q1022 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -37.88M | -36.90M | -46.69M | -63.43M | -51.03M | |||
| Depreciation Amortization | 35.20K | 153.30K | 210.00K | 260.00K | 270.00K | |||
| Change In Working Capital | 1.16M | -2.56M | -4.66M | -1.17M | 3.93M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 5.59M | 4.43M | 4.69M | 6.84M | 7.58M | |||
| OPERATING CASH FLOW | -31.10M | -34.88M | -46.46M | -57.49M | -39.24M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -10.00K | -21.40K | -80.00K | -10.00K | -70.00K | |||
| Other Investing Activity | 30.00K | N/A | 55.43M | 49.03M | 9.90M | |||
| INVESTING CASH FLOW | 20.00K | -21.40K | -80.00K | -10.00K | -70.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 5.40K | 28.82M | 4.16M | 10.72M | 18.14M | |||
| Dividend Paid | N/A | N/A | -45.03M | N/A | N/A | |||
| FINANCING CASH FLOW | 5.40K | 28.82M | 4.16M | 10.72M | 18.14M | |||
| CHANGE IN CASH | -31.07M | -6.08M | -42.38M | -46.78M | -21.17M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -31.10M | -34.88M | -46.46M | -57.49M | -39.24M | |||
| Capital Expenditure | -10.00K | -21.40K | -80.00K | -10.00K | -70.00K | |||
| FREE CASH FLOW | -31.11M | -34.90M | -46.54M | -57.50M | -39.31M | |||
All data in USD